The Virtune Avalanche ETP (Ticker: SE:VIRAVAX) is an innovative exchange-traded product designed for investors seeking exposure to the dynamic world of cryptocurrencies while strategically hedging against traditional fiat currency fluctuations. This ETF falls under the category of a Basket focused on Long Cryptocurrency Basket, Short USD, making it an intriguing choice for those looking to capitalize on the potential growth of digital assets while mitigating risks associated with the US dollar.
The Virtune Avalanche ETP offers a diversified portfolio of leading cryptocurrencies, providing investors with a comprehensive approach to capturing the upside of the burgeoning crypto market. By maintaining a long position in a selected basket of cryptocurrencies, the fund aims to deliver robust returns driven by the expanding adoption and technological advancements within the digital currency space.
Simultaneously, the fund employs a short position against the US dollar, offering a unique hedge that can potentially enhance returns during periods of USD depreciation. This dual-strategy approach not only provides a buffer against currency risks but also aligns with the growing trend of digital assets as a viable alternative to traditional monetary systems.
Catering to investors who are both crypto enthusiasts and those looking to diversify their portfolios with cutting-edge financial products, the Virtune Avalanche ETP stands out in the In Specie niche. It combines the growth potential of cryptocurrencies with a strategic hedge against fiat currency, making it a compelling choice for forward-thinking investors aiming to navigate the evolving financial landscape.
Virtune Avalanche ETP (VIRAVAX) Fund Flow Chart
Virtune Avalanche ETP (VIRAVAX) 1 year Net Flows: 32M
VIRAVAX ETF FAQ
What was SE:VIRAVAX’s price range in the past 12 months?
SE:VIRAVAX lowest ETF price was 1.44 and its highest was 6.08 in the past 12 months.
What is the AUM of SE:VIRAVAX?
As of Jul 16, 2025 The AUM of SE:VIRAVAX is 24.83M.
Is SE:VIRAVAX overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does SE:VIRAVAX pay dividends?
SE:VIRAVAX does not currently pay dividends.
How many shares outstanding does SE:VIRAVAX have?
Currently, no data Available
Which hedge fund is a major shareholder of SE:VIRAVAX?
Currently, no hedge funds are holding shares in SE:VIRAVAX